Related Experiment Video
Updated: Apr 21, 2026
05:39
Spontaneous Murine Model of Anaplastic Thyroid Cancer
Published on: February 3, 2023
2.1K
Genetic predisposition for nonmedullary thyroid cancer.
Rebecca Nagy1, Matthew D Ringel
1Divison of Human Genetics, The Ohio State University College of Medicine and Arthur G. James Comprehensive Cancer Center and Richard G. Solove Research Institute, Columbus, OH, 43210, USA, rebecca.nagy@osumc.edu.
Hormones & Cancer
|October 23, 2014
Summary
Nonmedullary thyroid cancer (NMTC) has a strong genetic basis, often occurring in families. Modern genomic research is identifying genes that predispose individuals to NMTC, advancing our understanding of its complex nature.
Area of Science:
- Oncology
- Genetics
- Genomics
Background:
- Nonmedullary thyroid cancer (NMTC) can be sporadic or part of hereditary cancer syndromes.
- Familial nonmedullary thyroid cancer (FNMTC) suggests a genetic predisposition.
- A significant genetic component of NMTC is suspected but largely uncharacterized.
Purpose of the Study:
- To review current knowledge on hereditary causes of NMTC.
- To present recent genomic findings on NMTC susceptibility genes.
- To elucidate the genetic underpinnings of NMTC predisposition.
Main Methods:
- Review of hereditary cancer syndromes associated with NMTC.
- Analysis of recent genomic studies identifying NMTC susceptibility genes.
- Integration of population-based and familial data.
Main Results:
- Hereditary cancer syndromes account for some NMTC cases.
- Modern genomic approaches are beginning to identify novel NMTC predisposition genes.
- The genetic architecture of NMTC is complex and only partially understood.
Conclusions:
- NMTC has a substantial genetic basis, extending beyond known syndromes.
- Genomic advancements are crucial for uncovering NMTC susceptibility genes.
- Further research is needed to fully characterize the genetic landscape of NMTC.
Related Concept Videos
01:28Graves' Disease I: Introduction
7
Graves' disease is an autoimmune disorder that causes hyperthyroidism, or overactivity of the thyroid gland. It results from autoantibodies called thyroid-stimulating immunoglobulins (TSIs), which bind to thyroid-stimulating hormone (TSH) receptors, leading to overstimulation of hormone production and a hypermetabolic state.EtiologyAlthough considered idiopathic, Graves’ disease has well-established contributing factors. There is a strong genetic component, with increased prevalence...
7
01:11Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase
80
Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...
80
02:59Cancer Prevention
6.5K
Several factors can increase the risk of cancer in an individual. About 50% of cancer cases can be prevented by adopting a healthy lifestyle, regular exercise, eating healthy, and following a modest cancer prevention diet. Epidemiological studies have consistently shown that populations with vegetable and fruit-rich diets have reduced the incidence of cancer. On the other hand, populations who have a diet rich in animal fat, red meat, junk food, or high calories are predisposed to cancer.
Some...
Some...
6.5K
01:27Hyperthyroidism II: Pathophysiology
8
Hyperthyroidism is a hypermetabolic state caused by elevated levels of thyroid hormones, triiodothyronine (T3) and thyroxine (T4). It results from dysregulation at the thyroid, pituitary, or immune system level and affects multiple organ systems.PathophysiologyThe most common cause of hyperthyroidism is Graves’ disease, an autoimmune disorder in which antibodies, specifically thyroid-stimulating antibodies (TSAb), a subtype of TSH receptor antibodies (TRAb), bind to and activate TSH...
8
01:25Hyperthyroidism I: Introduction
7
Hyperthyroidism is a type of thyrotoxicosis characterized by the thyroid gland's overproduction of the thyroid hormones triiodothyronine (T3) and thyroxine (T4). This hormone excess increases the basal metabolic rate and enhances sensitivity to catecholamines.DiagnosisDiagnosis is based on clinical features and biochemical testing. It typically shows suppressed thyroid-stimulating hormone (TSH) levels below 0.4 mIU/L, with elevated free T3 and/or T4. Additional tests, including thyroid...
7
01:24Graves Disease II: Pathophysiology
8
Graves’ disease is an autoimmune disorder characterized by the production of thyroid-stimulating immunoglobulins (TSI) that activate TSH receptors, leading to excessive synthesis and release of thyroid hormones (T3 and T4) and resulting in hyperthyroidism.Among all causes of hyperthyroidism, Graves’ disease is the most common and can happen at any age, though it is more frequent in women. It produces a hypermetabolic state with features such as weight loss, tachycardia, tremor,...
8